LXU LSB INDUSTRIES, INC.
Industrial Inorganic Chemicals · NYSE · SEC CIK 60714 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY13.0%
TTM net income YoY6,982.5%
TTM EPS YoY6,400.0%
Revenue 3-yr CAGR-1.6%
Net income 3-yr CAGR-22.6%
Margins
Gross margin19.9%
Operating margin11.2%
Net margin7.0%
FCF margin9.7%
EBITDA margin24.3%
Returns
ROE8.7%
ROA3.9%
ROIC (approx.)6.9%
Asset turnover0.56x
Leverage & solvency
Liabilities / assets54.4%
Debt / equity0.79x
Current ratio3.01x
Interest coverage2.61x
Cash quality & payout
Operating cash flow / net income3.25x
Accruals ratio-8.7%
Payout ratio—
Capex / revenue12.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $158.60M | $168.09M | $169.49M | $165.05M | $155.43M | $151.30M | $143.43M | $134.91M |
| Cost of revenue | $115.50M | $156.63M | $133.69M | $123.85M | $129.89M | $128.12M | $129.05M | $128.86M |
| Gross profit | $43.10M | $11.46M | $35.79M | $41.20M | $25.54M | $23.17M | $14.38M | $6.05M |
| SG&A expense | $14.76M | $12.93M | $13.82M | $11.18M | $10.33M | $9.84M | $10.15M | $9.88M |
| Operating income | $26.81M | -$2.74M | $23.16M | $26.68M | $15.63M | $10.49M | $4.47M | -$6.75M |
| Interest expense | $6.75M | $7.07M | $7.12M | $7.34M | $7.36M | $7.89M | $8.06M | $8.22M |
| Pretax income | $21.89M | -$8.11M | $17.55M | $20.73M | $9.65M | $4.09M | -$1.92M | -$13.20M |
| Income tax | $5.54M | -$1.92M | -$2.13M | $4.60M | $2.54M | $1.08M | -$283,000 | -$4.05M |
| Net income | $16.35M | -$6.19M | $19.68M | $16.13M | $7.12M | $3.01M | -$1.64M | -$9.15M |
| EBITDA | $49.14M | $19.20M | $44.08M | $48.47M | $35.01M | $31.14M | $24.62M | $15.05M |
| EPS (basic) | 0.23 | -0.09 | 0.27 | — | 0.10 | 0.04 | -0.02 | — |
| EPS (diluted) | 0.22 | -0.09 | 0.27 | — | 0.10 | 0.04 | -0.02 | — |
| Weighted avg. shares (diluted) | 73.30M | 72.44M | 73.06M | — | 72.47M | 72.15M | 71.84M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $37.70M | $20.36M | $20.64M | $19.51M | $27.95M | $5.61M | $15.03M | $20.23M |
| Short-term investments | $165.78M | $197.62M | $161.04M | $128.96M | $124.02M | $119.28M | $148.52M | $163.97M |
| Receivables | $57.46M | $52.69M | $52.50M | $57.21M | $46.65M | $51.29M | $51.87M | $38.76M |
| Inventory | $20.88M | $15.85M | $23.24M | $18.31M | $19.80M | $24.45M | $25.49M | $24.90M |
| Current assets | $342.97M | $345.57M | $321.30M | $293.29M | $270.62M | $255.21M | $299.33M | $309.71M |
| PP&E, net | $831.07M | $833.24M | $825.57M | $833.52M | $833.25M | $838.03M | $842.51M | $847.57M |
| Total assets | $1.22B | $1.22B | $1.19B | $1.17B | $1.15B | $1.13B | $1.18B | $1.19B |
| Current liabilities | $113.91M | $142.47M | $104.56M | $105.51M | $95.30M | $96.51M | $119.47M | $135.63M |
| Short-term debt | $888,000 | $774,000 | $770,000 | $760,000 | $817,000 | $6.25M | $7.76M | $9.12M |
| Long-term debt | $441.27M | $440.57M | $440.43M | $440.30M | $447.58M | $446.37M | $478.17M | $476.16M |
| Total debt | $442.16M | $441.35M | $441.20M | $441.06M | $448.40M | $452.62M | $485.93M | $485.28M |
| Total liabilities | $666.41M | $685.38M | $648.41M | $653.57M | $644.94M | $632.28M | $685.38M | $695.55M |
| Shareholders' equity | $558.11M | $539.22M | $542.95M | $519.97M | $504.61M | $495.80M | $490.56M | $491.64M |
| Net debt | $404.46M | $420.99M | $420.56M | $421.54M | $420.45M | $447.01M | $470.90M | $465.05M |
| Cash flow statement | ||||||||
| Operating cash flow | $20.50M | $59.36M | $51.80M | $17.95M | $52.57M | $18.16M | $6.84M | $3.98M |
| Capital expenditure | $18.11M | $29.27M | $16.98M | $21.14M | $16.98M | $18.48M | $20.87M | $28.21M |
| Free cash flow | $2.39M | $30.09M | $34.82M | -$3.19M | $35.60M | -$315,000 | -$14.03M | -$24.23M |
| Investing cash flow | $682,000 | -$55.47M | -$45.48M | -$25.41M | -$21.77M | $10.10M | -$5.27M | -$34.70M |
| Financing cash flow | -$3.84M | -$4.17M | -$5.19M | -$973,000 | -$8.47M | -$37.68M | -$6.76M | $8.67M |
| Depreciation & amortization | $22.33M | $21.95M | $20.92M | $21.79M | $19.38M | $20.65M | $20.15M | $21.79M |
| Stock-based compensation | $2.54M | $2.88M | $4.79M | $1.83M | $1.72M | $2.09M | $1.73M | $1.56M |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.